ERBB2 and neoplasm: The HER-2 positive subset of pure apocrine carcinoma shows transcriptional overlap with the molecular signature of the so called [12] molecular apocrine tumours (MATs) [51, 60] and the triple negative subset with a cohort of triple negative breast cancers (TNBCs) known as luminal androgen receptor (LAR) tumours [61], discussed below.